Shenzhen, China

Ruixia Song


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ruixia Song in Biomedical Technology

Introduction

Ruixia Song is a prominent inventor based in Shenzhen, China. She has made significant contributions to the field of biomedical technology, particularly in the preparation of simulating particles that mimic blood components. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics and research.

Latest Patents

Ruixia Song's latest patents include a method for preparing reticulocyte simulating particles and platelet simulating particles, along with a reference control. The method involves staining mammalian anucleated red blood cells with a protein fluorescent dye activated by N-hydroxysuccinimide. This process allows for the preparation of reticulocyte simulating particles, which are crucial for understanding blood cell dynamics. Additionally, her patent on erythrocyte simulating particles outlines a preparation method that ensures stability and similarity to natural erythrocyte particles, enhancing their utility in clinical settings.

Career Highlights

Ruixia Song is currently employed at Shenzhen Mindray Bio-medical Electronics Co., Ltd. Her role at this leading biomedical company allows her to apply her innovative ideas in practical applications, contributing to the development of advanced medical technologies.

Collaborations

She collaborates with notable colleagues such as Jian Xie and Bo Liu, who share her passion for innovation in the biomedical field. Their teamwork fosters an environment of creativity and scientific exploration.

Conclusion

Ruixia Song's contributions to biomedical technology through her innovative patents are significant. Her work not only enhances the understanding of blood components but also improves diagnostic methods in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…